Literature DB >> 23959267

Targeted therapies: Hope for antiangiogenic therapy in advanced gastric cancer.

Mina Razzak.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23959267     DOI: 10.1038/nrclinonc.2013.156

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Apatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trial.

Authors:  Jin Li; Shukui Qin; Jianming Xu; Weijian Guo; Jianping Xiong; Yuxian Bai; Guoping Sun; Yan Yang; Liwei Wang; Nong Xu; Ying Cheng; Zhehai Wang; Leizhen Zheng; Min Tao; Xiaodong Zhu; Dongmei Ji; Xin Liu; Hao Yu
Journal:  J Clin Oncol       Date:  2013-08-05       Impact factor: 44.544

  1 in total
  1 in total

1.  Y-box binding protein 1 expression in gastric cancer subtypes and association with cancer neovasculature.

Authors:  Y Wu; K-Y Wang; Z Li; Y-P Liu; H Izumi; S Yamada; H Uramoto; Y Nakayama; K Ito; K Kohno
Journal:  Clin Transl Oncol       Date:  2014-07-31       Impact factor: 3.405

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.